⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of MedChemExpress (MCE) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
MedChemExpress (MCE)
↗Monmouth Junction, USA (Global/US HQ); Shanghai, China (Parent HQ)
MedChemExpress (MCE) is a leading global supplier of research chemicals, bioactive compounds, and drug discovery solutions. The company provides an extensive portfolio including over 150,000 small molecules, compound libraries, recombinant proteins, and antibodies to support pharmaceutical and biotech research from early discovery to therapeutic advancement.
Beyond product supply, MCE operates as a CRO/CDMO, offering integrated discovery services such as DNA-encoded library (DEL) screening, high-throughput screening (HTS), custom synthesis, and process development. It is a subsidiary of Shanghai Haoyuan Chemexpress Co., Ltd., which is publicly listed on the SSE Star Market (688131).
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Life Science Reagents & Drug Discovery Services
SIZE & FINANCIALS
Employees:1001-5000
Founded:2009
Ownership:subsidiary
Status:operating
STOCK
Exchange:SSE Star Market (Parent: 688131)
Ticker:688131
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, ADC, Peptides, PROTACs
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Shanghai Haoyuan Chemexpress Co., Ltd.
Key Partnerships:Scientist.com (Distribution), Various academic and pharmaceutical research institutions
COMPETITION
Position:Leader
Competitors:Cayman Chemical, Selleck Chemicals, Prestwick Chemical
LINKS
Website:medchemexpress.cn
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with MedChemExpress (MCE). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.